Apr 22, 2026 01:09AM
Apr 22, 2026 01:05AM
Feb 17, 2026 08:30AM
Jan 23, 2026 01:00AM
Jan 15, 2026 06:02AM
Jan 5, 2026 02:06PM
Jan 5, 2026 02:05PM FDA approves Sanofi's Cablivi for pediatric blood clotting disorder
Dec 28, 2025 01:48AM
Dec 24, 2025 04:01AM
Dec 23, 2025 09:16AM
Dec 23, 2025 09:06AM
Dec 19, 2025 02:22PM
Dec 19, 2025 02:21PM
Nov 25, 2025 01:00AM Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Oct 28, 2025 02:00AM
Oct 20, 2025 07:30AM
Oct 20, 2025 07:30AM
Oct 2, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 25, 2025 02:23PM
Sep 22, 2025 01:00AM Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
Sep 10, 2025 08:00AM
Aug 29, 2025 05:50PM
Jul 22, 2025 11:57AM
Jun 2, 2025 05:40AM
Jun 2, 2025 01:25AM
May 21, 2025 07:23PM
May 21, 2025 07:15PM Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
May 14, 2025 12:32PM
May 14, 2025 12:30PM
Apr 30, 2025 07:00AM
Apr 24, 2025 01:39AM
Apr 21, 2025 04:05PM
Apr 18, 2025 11:15AM
Apr 8, 2025 01:10PM Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
Mar 28, 2025 04:07PM
Mar 28, 2025 03:15PM
Mar 28, 2025 02:34PM
Mar 28, 2025 02:30PM
Mar 28, 2025 02:00AM
Mar 14, 2025 02:21PM
Mar 14, 2025 02:18PM Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
Feb 20, 2025 12:12PM
Feb 19, 2025 01:30AM
Dec 10, 2024 08:30AM
Dec 9, 2024 02:06PM
Nov 15, 2024 12:59AM
Nov 14, 2024 11:42AM
Nov 6, 2024 01:00AM Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis
Oct 21, 2024 01:30AM

322,850 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All